Xianghua Wu

7PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 11, 2026
Bevacizumab plus nab-paclitaxel and platinum as second-line therapy for driver-gene-negative non-squamous non-small cell lung cancer after immunochemotherapy: A prospective single-arm single-centre study.

|Oct 14, 2022
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study.

Xin Liu, Shiyu Jiang, Huijie Wang

|Feb 14, 2022
A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity.

Lanlin Zhang, Jiangyuan Du, Qian Song

|Jan 04, 2020
Transcription factor RUNX3 promotes CD8+ T cell recruitment by CCL3 and CCL20 in lung adenocarcinoma immune microenvironment.

Qian Song, Jun Shang, Chufan Zhang

|Mar 06, 2019
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.

Qian Song, Jun Shang, Zuyi Yang

|Jan 04, 2019
Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients.

Qian Song, Jun Shang, Chufan Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Jun Shang

1 joint publications

Xin Liu

1 joint publications

Shiyu Jiang

1 joint publications

Huijie Wang